0001192482-20-000740.txt : 20200930
0001192482-20-000740.hdr.sgml : 20200930
20200930135813
ACCESSION NUMBER: 0001192482-20-000740
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200929
FILED AS OF DATE: 20200930
DATE AS OF CHANGE: 20200930
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEFF JONATHAN S
CENTRAL INDEX KEY: 0001215242
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 201211826
MAIL ADDRESS:
STREET 1: C/O DEERFIELD MANAGEMENT COMPANY, L.P
STREET 2: 780 THIRD AVENUE, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Larimar Therapeutics, Inc.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
BUSINESS PHONE: 844-511-9056
MAIL ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN, INC.
DATE OF NAME CHANGE: 20100301
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-09-29
0001374690
Larimar Therapeutics, Inc.
LRMR
0001215242
LEFF JONATHAN S
C/O LARIMAR THERAPEUTICS, INC.
THREE BALA PLAZA EAST, SUITE 506
BALA CYNWYD
PA
19004
1
0
0
0
Stock Option (right to buy)
11.9
2020-09-29
4
A
0
16600
0
A
2030-07-16
Common Stock
16600
16600
D
The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P.
The Option was granted on July 16, 2020 subject to stockholder approval, which was obtained at the Company's special meeting of stockholders on September 29, 2020. The vesting commencement date for the option is July 16, 2020, and the option vests in equal monthly installments over 36 months, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.
/s/ Jennifer Johansson, Attorney-in-fact
2020-09-30